Rubric Capital Management LP Heron Therapeutics, Inc. Transaction History

Rubric Capital Management LP

$6.05 Billion
Q4 2024

A detailed history of Rubric Capital Management LP transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Rubric Capital Management LP holds 26,713,503 shares of HRTX stock, worth $45.9 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

26,713,503

Previous 26,713,503 -0.0%

Holding current value

$45.9 Million

Previous $53.2 Million 23.12%

% of portfolio

0.68%

Previous 1.48%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$0.97 - $1.8 $14.5 Million - $26.9 Million	14,963,503 Added 127.35%	26,713,503 $27.5 Million
Q4 2022 Feb 10, 2023	BUY	$2.25 - $4.67 $20.8 Million - $43.1 Million	9,233,672 Added 366.95%	11,750,000 $29.4 Million
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $6.69 Million - $13.5 Million	2,516,328 New	2,516,328 $10.6 Million
Q2 2019 Aug 13, 2019	SELL	$16.93 - $26.22 $25.4 Million - $39.3 Million	-1,500,000 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$23.15 - $28.34 $29.8 Million - $36.5 Million	-1,287,592 Reduced 46.19%	1,500,000 $36.7 Million
Q4 2018 Feb 13, 2019	BUY	$22.03 - $32.01 $18.3 Million - $26.5 Million	828,742 Added 42.31%	2,787,592 $72.3 Million
Q3 2018 Nov 13, 2018	BUY	$30.0 - $40.85 $24.6 Million - $33.4 Million	818,603 Added 71.79%	1,958,850 $62 Million
Q2 2018 Aug 14, 2018	SELL	$26.4 - $42.0 $9.76 Million - $15.5 Million	-369,761 Reduced 24.49%	1,140,247 $44.3 Million
Q1 2018 May 14, 2018	SELL	$18.43 - $28.8 $12.7 Million - $19.8 Million	-687,304 Reduced 31.28%	1,510,008 $41.7 Million
Q4 2017 Feb 14, 2018	BUY	$14.8 - $18.85 $4.4 Million - $5.6 Million	297,312 Added 15.65%	2,197,312 $39.8 Million
Q3 2017 Nov 13, 2017	BUY	$14.65 - $16.85 $27.8 Million - $32 Million	1,900,000	1,900,000 $30.7 Million

Others Institutions Holding HRTX

# of Institutions

173

Shares Held

114M

Call Options Held

Put Options Held

32.4K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $204M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Account

Rubric Capital Management LP Heron Therapeutics, Inc. Transaction History